_version_ 1784802077079240704
author Koenecke, Christian
Eikema, Dirk-Jan
Hazelaar, Sheree
Schroeder, Thomas
Potter, Victoria
Kröger, Nicolaus
Bornhäuser, Martin
Finke, Jürgen
Platzbecker, Uwe
Radujkovic, Aleksandar
Ganser, Arnold
Salmenniem, Urpu
Blaise, Didier
Kobbe, Guido
Meijer, Ellen
Friis, Lone
Maertens, Johan
Caballero, Dolores
Cornelissen, Jan J.
Olivieri, Attilio
Gulsum, Ozet
Hayden, Patrick J.
Onida, Francesco
Robin, Marie
Yakoub-Agha, Ibrahim
author_facet Koenecke, Christian
Eikema, Dirk-Jan
Hazelaar, Sheree
Schroeder, Thomas
Potter, Victoria
Kröger, Nicolaus
Bornhäuser, Martin
Finke, Jürgen
Platzbecker, Uwe
Radujkovic, Aleksandar
Ganser, Arnold
Salmenniem, Urpu
Blaise, Didier
Kobbe, Guido
Meijer, Ellen
Friis, Lone
Maertens, Johan
Caballero, Dolores
Cornelissen, Jan J.
Olivieri, Attilio
Gulsum, Ozet
Hayden, Patrick J.
Onida, Francesco
Robin, Marie
Yakoub-Agha, Ibrahim
author_sort Koenecke, Christian
collection PubMed
description
format Online
Article
Text
id pubmed-9532241
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-95322412022-10-06 Prognostic value of CPSS cytogenetic risk classification in patients with CMML after allogeneic hematopoietic cell transplantation: a retrospective multicenter study of the Chronic Malignancies Working Party of the EBMT Koenecke, Christian Eikema, Dirk-Jan Hazelaar, Sheree Schroeder, Thomas Potter, Victoria Kröger, Nicolaus Bornhäuser, Martin Finke, Jürgen Platzbecker, Uwe Radujkovic, Aleksandar Ganser, Arnold Salmenniem, Urpu Blaise, Didier Kobbe, Guido Meijer, Ellen Friis, Lone Maertens, Johan Caballero, Dolores Cornelissen, Jan J. Olivieri, Attilio Gulsum, Ozet Hayden, Patrick J. Onida, Francesco Robin, Marie Yakoub-Agha, Ibrahim Bone Marrow Transplant Correspondence Nature Publishing Group UK 2022-07-23 2022 /pmc/articles/PMC9532241/ /pubmed/35871086 http://dx.doi.org/10.1038/s41409-022-01759-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Correspondence
Koenecke, Christian
Eikema, Dirk-Jan
Hazelaar, Sheree
Schroeder, Thomas
Potter, Victoria
Kröger, Nicolaus
Bornhäuser, Martin
Finke, Jürgen
Platzbecker, Uwe
Radujkovic, Aleksandar
Ganser, Arnold
Salmenniem, Urpu
Blaise, Didier
Kobbe, Guido
Meijer, Ellen
Friis, Lone
Maertens, Johan
Caballero, Dolores
Cornelissen, Jan J.
Olivieri, Attilio
Gulsum, Ozet
Hayden, Patrick J.
Onida, Francesco
Robin, Marie
Yakoub-Agha, Ibrahim
Prognostic value of CPSS cytogenetic risk classification in patients with CMML after allogeneic hematopoietic cell transplantation: a retrospective multicenter study of the Chronic Malignancies Working Party of the EBMT
title Prognostic value of CPSS cytogenetic risk classification in patients with CMML after allogeneic hematopoietic cell transplantation: a retrospective multicenter study of the Chronic Malignancies Working Party of the EBMT
title_full Prognostic value of CPSS cytogenetic risk classification in patients with CMML after allogeneic hematopoietic cell transplantation: a retrospective multicenter study of the Chronic Malignancies Working Party of the EBMT
title_fullStr Prognostic value of CPSS cytogenetic risk classification in patients with CMML after allogeneic hematopoietic cell transplantation: a retrospective multicenter study of the Chronic Malignancies Working Party of the EBMT
title_full_unstemmed Prognostic value of CPSS cytogenetic risk classification in patients with CMML after allogeneic hematopoietic cell transplantation: a retrospective multicenter study of the Chronic Malignancies Working Party of the EBMT
title_short Prognostic value of CPSS cytogenetic risk classification in patients with CMML after allogeneic hematopoietic cell transplantation: a retrospective multicenter study of the Chronic Malignancies Working Party of the EBMT
title_sort prognostic value of cpss cytogenetic risk classification in patients with cmml after allogeneic hematopoietic cell transplantation: a retrospective multicenter study of the chronic malignancies working party of the ebmt
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9532241/
https://www.ncbi.nlm.nih.gov/pubmed/35871086
http://dx.doi.org/10.1038/s41409-022-01759-7
work_keys_str_mv AT koeneckechristian prognosticvalueofcpsscytogeneticriskclassificationinpatientswithcmmlafterallogeneichematopoieticcelltransplantationaretrospectivemulticenterstudyofthechronicmalignanciesworkingpartyoftheebmt
AT eikemadirkjan prognosticvalueofcpsscytogeneticriskclassificationinpatientswithcmmlafterallogeneichematopoieticcelltransplantationaretrospectivemulticenterstudyofthechronicmalignanciesworkingpartyoftheebmt
AT hazelaarsheree prognosticvalueofcpsscytogeneticriskclassificationinpatientswithcmmlafterallogeneichematopoieticcelltransplantationaretrospectivemulticenterstudyofthechronicmalignanciesworkingpartyoftheebmt
AT schroederthomas prognosticvalueofcpsscytogeneticriskclassificationinpatientswithcmmlafterallogeneichematopoieticcelltransplantationaretrospectivemulticenterstudyofthechronicmalignanciesworkingpartyoftheebmt
AT pottervictoria prognosticvalueofcpsscytogeneticriskclassificationinpatientswithcmmlafterallogeneichematopoieticcelltransplantationaretrospectivemulticenterstudyofthechronicmalignanciesworkingpartyoftheebmt
AT krogernicolaus prognosticvalueofcpsscytogeneticriskclassificationinpatientswithcmmlafterallogeneichematopoieticcelltransplantationaretrospectivemulticenterstudyofthechronicmalignanciesworkingpartyoftheebmt
AT bornhausermartin prognosticvalueofcpsscytogeneticriskclassificationinpatientswithcmmlafterallogeneichematopoieticcelltransplantationaretrospectivemulticenterstudyofthechronicmalignanciesworkingpartyoftheebmt
AT finkejurgen prognosticvalueofcpsscytogeneticriskclassificationinpatientswithcmmlafterallogeneichematopoieticcelltransplantationaretrospectivemulticenterstudyofthechronicmalignanciesworkingpartyoftheebmt
AT platzbeckeruwe prognosticvalueofcpsscytogeneticriskclassificationinpatientswithcmmlafterallogeneichematopoieticcelltransplantationaretrospectivemulticenterstudyofthechronicmalignanciesworkingpartyoftheebmt
AT radujkovicaleksandar prognosticvalueofcpsscytogeneticriskclassificationinpatientswithcmmlafterallogeneichematopoieticcelltransplantationaretrospectivemulticenterstudyofthechronicmalignanciesworkingpartyoftheebmt
AT ganserarnold prognosticvalueofcpsscytogeneticriskclassificationinpatientswithcmmlafterallogeneichematopoieticcelltransplantationaretrospectivemulticenterstudyofthechronicmalignanciesworkingpartyoftheebmt
AT salmenniemurpu prognosticvalueofcpsscytogeneticriskclassificationinpatientswithcmmlafterallogeneichematopoieticcelltransplantationaretrospectivemulticenterstudyofthechronicmalignanciesworkingpartyoftheebmt
AT blaisedidier prognosticvalueofcpsscytogeneticriskclassificationinpatientswithcmmlafterallogeneichematopoieticcelltransplantationaretrospectivemulticenterstudyofthechronicmalignanciesworkingpartyoftheebmt
AT kobbeguido prognosticvalueofcpsscytogeneticriskclassificationinpatientswithcmmlafterallogeneichematopoieticcelltransplantationaretrospectivemulticenterstudyofthechronicmalignanciesworkingpartyoftheebmt
AT meijerellen prognosticvalueofcpsscytogeneticriskclassificationinpatientswithcmmlafterallogeneichematopoieticcelltransplantationaretrospectivemulticenterstudyofthechronicmalignanciesworkingpartyoftheebmt
AT friislone prognosticvalueofcpsscytogeneticriskclassificationinpatientswithcmmlafterallogeneichematopoieticcelltransplantationaretrospectivemulticenterstudyofthechronicmalignanciesworkingpartyoftheebmt
AT maertensjohan prognosticvalueofcpsscytogeneticriskclassificationinpatientswithcmmlafterallogeneichematopoieticcelltransplantationaretrospectivemulticenterstudyofthechronicmalignanciesworkingpartyoftheebmt
AT caballerodolores prognosticvalueofcpsscytogeneticriskclassificationinpatientswithcmmlafterallogeneichematopoieticcelltransplantationaretrospectivemulticenterstudyofthechronicmalignanciesworkingpartyoftheebmt
AT cornelissenjanj prognosticvalueofcpsscytogeneticriskclassificationinpatientswithcmmlafterallogeneichematopoieticcelltransplantationaretrospectivemulticenterstudyofthechronicmalignanciesworkingpartyoftheebmt
AT olivieriattilio prognosticvalueofcpsscytogeneticriskclassificationinpatientswithcmmlafterallogeneichematopoieticcelltransplantationaretrospectivemulticenterstudyofthechronicmalignanciesworkingpartyoftheebmt
AT gulsumozet prognosticvalueofcpsscytogeneticriskclassificationinpatientswithcmmlafterallogeneichematopoieticcelltransplantationaretrospectivemulticenterstudyofthechronicmalignanciesworkingpartyoftheebmt
AT haydenpatrickj prognosticvalueofcpsscytogeneticriskclassificationinpatientswithcmmlafterallogeneichematopoieticcelltransplantationaretrospectivemulticenterstudyofthechronicmalignanciesworkingpartyoftheebmt
AT onidafrancesco prognosticvalueofcpsscytogeneticriskclassificationinpatientswithcmmlafterallogeneichematopoieticcelltransplantationaretrospectivemulticenterstudyofthechronicmalignanciesworkingpartyoftheebmt
AT robinmarie prognosticvalueofcpsscytogeneticriskclassificationinpatientswithcmmlafterallogeneichematopoieticcelltransplantationaretrospectivemulticenterstudyofthechronicmalignanciesworkingpartyoftheebmt
AT yakoubaghaibrahim prognosticvalueofcpsscytogeneticriskclassificationinpatientswithcmmlafterallogeneichematopoieticcelltransplantationaretrospectivemulticenterstudyofthechronicmalignanciesworkingpartyoftheebmt